Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Apexigen
Biotech
Hoping to pave a longer runway, Pyxis cuts staff, reprioritizes
Pyxis Oncology needs to pave a longer cash runway. It'll take some drastic measures including layoffs and program reprioritizations to get there.
Annalee Armstrong
Nov 8, 2023 5:00am
Apexigen accepts Pyxis' $16M bid 300 days after going public
May 24, 2023 9:20am
Months after going public, Apexigen lays off 55% of staff
Feb 27, 2023 9:40am
Sanofi's John Reed jumps ship for J&J—Chutes & Ladders
Feb 17, 2023 9:30am
After megaround, Apexigen inks modest SPAC deal for cancer R&D
Mar 18, 2022 7:45am
Apexigen wows at AACR with I-O combo in pancreatic cancer
Apr 1, 2019 9:05am
